Related Experiment Video
Updated: Jun 22, 2026
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Macelignan attenuates activations of mitogen-activated protein kinases and nuclear factor kappa B induced by
Jinhua Ma1, Yoo Kyeong Hwang, Woo-Hyun Cho
1Department of Biological Sciences & Center for Geriatric Neuroscience Research, IBST, Konkuk University, Seoul, South Korea.
Abstract:
A previous study showed that macelignan extracted from Myristica fragrans has anti-inflammatory properties using hippocampal neuronal and primary microglial cells. Subsequently, a study using animals with chronic lipopolysaccharide (LPS) infusion into the brain showed that oral treatments of macelignan reduced the hippocampal microglial activation and hippocampal-dependent spatial memory impairments induced by LPS. However, the molecular mechanisms responsible for the anti-inflammatory activity of macelignan have not been elucidated in the microglia. Therefore, the present study was conducted to determine if mitogen-activated protein kinase (MAPK) signaling and nuclear factor-kappa B (NF-kappaB) activities are related to the anti-inflammatory effects of macelignan on LPS-stimulated BV-2 microglial cells. The results show that macelignan suppresses both the phosphorylations of MAPKs and the degradation of inhibitory-kappa B (IkappaBalpha) and increases of nuclear NF-kappaB in LPS-stimulated BV-2 microglial cells. These results suggest that macelignan has an anti-inflammatory effect on the affected brain through regulation of the inflammation through the MAPK signal pathway.
Insights
Macelignan, derived from Myristica fragrans, reduces brain inflammation by inhibiting key signaling pathways in microglial cells. This compound regulates mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kappaB) activities, offering potential therapeutic benefits.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Macelignan from Myristica fragrans exhibits anti-inflammatory properties.
- Previous studies linked macelignan to reduced microglial activation and improved spatial memory in LPS-infused animal models.
- The precise molecular mechanisms of macelignan's anti-inflammatory action in microglia remain unclear.
Purpose of the Study:
- To investigate the molecular mechanisms underlying macelignan's anti-inflammatory effects in LPS-stimulated BV-2 microglial cells.
- To determine the role of mitogen-activated protein kinase (MAPK) signaling and nuclear factor-kappa B (NF-kappaB) pathways in macelignan's action.
Main Methods:
- Utilized LPS-stimulated BV-2 microglial cells to model neuroinflammation.
- Assessed the impact of macelignan on MAPK phosphorylation levels.
- Evaluated changes in inhibitory-kappa B alpha (IkappaBalpha) degradation and nuclear translocation of NF-kappaB.
Main Results:
- Macelignan significantly suppressed the phosphorylation of MAPKs in LPS-stimulated BV-2 cells.
- Macelignan inhibited the degradation of IkappaBalpha, a key inhibitor of NF-kappaB.
- Macelignan treatment led to increased nuclear NF-kappaB levels in LPS-stimulated microglia.
Conclusions:
- Macelignan exerts anti-inflammatory effects in the brain by modulating MAPK signaling pathways.
- The study elucidates that macelignan's anti-inflammatory action involves the regulation of MAPK and NF-kappaB activities in microglial cells.
- These findings suggest macelignan as a potential therapeutic agent for neuroinflammatory conditions.
